Puma Biotechnology, Inc.

US$8.25As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PBYIHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (14.20%)
Div yield —
ROE 21.97%
Biotechnology
Beta (5Y) 1.33
PE TTM 18.15
TSR TTM 61.76%
Mkt cap US$425.9M
ROIC 44.74%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$11
28.70%
(48.59%)
Hold 3|4|7|8|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.15
0.16
0.17
0.18
21.73%
28.57%
18.84%
25.36%
Revenue$M
41.33
43.46
42.19
43.10
(1.82%)
(0.10%)
(0.23%)
2.87%
Peers (US$425.9M)
Cap (US$)
PE
419.8M
—
Capital
TTM
5Y
10Y
Leveragex
1.300
1.556
1.282
EBIT/Intx
2.047
0.226
0.220
Own earn%
(173.61)
(159.87)
(150.79)
Sh yield%
39.24
46.21
40.66
Owners
Insiders/Inst%
6.55
88.79
Short interest%
1.68
SBC / revenue%
2.83
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
9–14
$1 testx
0.1
Incr. ROIC%
19